Please try another search
Ryvu Therapeutics SA, formerly known as Selvita SA, is a Poland-based company engaged in the healthcare industry. The Company is active in the pharmaceutical and biotechnology fields. It operates through two business segments. The Innovative segment develops new drugs mainly for oncology and central nervous system diseases. The Services segment is engaged in the research and development activities, such as introducing substances on the market, client service and reducing the risk. The Company’s portfolio encompasses projects, including kinesis inhibitors platform, the platform of the metabolism for the cancer and epigenetic, among others. Ryvu Therapeutics SA is active in the domestic market and internationally, such as in the United States. It operates through unit Ardigen SA and SORS Holdings Ltd.
Name | Age | Since | Title |
---|---|---|---|
Piotr Romanowski | 54 | 2011 | Independent Chairman of the Supervisory Board |
Tadeusz Wesolowski | - | - | Non-Independent Vice Chairman of Supervisory Board |
Rafal Piotr Chwast | - | - | Independent Member of the Supervisory Board |
Axel Gaston Glasmacher | 64 | 2019 | Non-Independent Member of the Supervisory Board |
Peter G. Smith | - | 2023 | Member of Supervisory Board |
Scott Z. Fields | 70 | 2023 | Member of Supervisory Board |
Thomas Turalski | - | 2019 | Non-Independent Member of the Supervisory Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review